Dr. Baum speaks to CNETs Singapore on Theranostics.
Theranostics is the emerging field of molecular targeting of vectors which can be used for both therapies and diagnosis, when modified accordingly. For neuroendocrine tumor patients, it is well established that specific peptides may be used to target serotonin receptors on the tumors. In a well-equipped nuclear medicine department, these peptides can be bound with radioisotopes suited to either imaging or therapy - theranostics.